Global Selpercatinib Capsules Market Growth 2026-2032

February 2026 | 82 pages | ID: GB716D49054CEN
LP Information

Abstracts

The global Selpercatinib Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Selpercatinib, sold under the brand name Retevmo among others, is a medication for the treatment of cancers in people whose tumors have an alteration (mutation or fusion) in a specific gene. This medication is used to treat certain types of cancer (such as lung cancer, thyroid cancer, medullary thyroid cancer, certain other solid tumors).

United States market for Selpercatinib Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Selpercatinib Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Selpercatinib Capsules is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Selpercatinib Capsules players cover Eli Lilly, Innovnent Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Selpercatinib Capsules Industry Forecast” looks at past sales and reviews total world Selpercatinib Capsules sales in 2025, providing a comprehensive analysis by region and market sector of projected Selpercatinib Capsules sales for 2026 through 2032. With Selpercatinib Capsules sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Selpercatinib Capsules industry.

This Insight Report provides a comprehensive analysis of the global Selpercatinib Capsules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Selpercatinib Capsules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Selpercatinib Capsules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Selpercatinib Capsules and breaks down the forecast by Specification, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Selpercatinib Capsules.

This report presents a comprehensive overview, market shares, and growth opportunities of Selpercatinib Capsules market by product type, application, key manufacturers and key regions and countries.

Segmentation by Specification:

• 40mg
• 80mg

Segmentation by Application:

• Non-Small Cell Lung Cancer (NSCLC)
• Thyroid Carcinoma
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Eli Lilly
• Innovnent Biologics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Selpercatinib Capsules market?

What factors are driving Selpercatinib Capsules market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Selpercatinib Capsules market opportunities vary by end market size?

How does Selpercatinib Capsules break out by Specification, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Selpercatinib Capsules Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Selpercatinib Capsules by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Selpercatinib Capsules by Country/Region, 2021, 2025 & 2032
2.2 Selpercatinib Capsules Segment by Specification
  2.2.1 40mg
  2.2.2 80mg
  2.2.3 Selpercatinib Capsules Sales by Specification
    2.2.3.1 Global Selpercatinib Capsules Sales Market Share by Specification (2021-2026)
    2.2.3.2 Global Selpercatinib Capsules Revenue and Market Share by Specification (2021-2026)
    2.2.3.3 Global Selpercatinib Capsules Sale Price by Specification (2021-2026)
2.3 Selpercatinib Capsules Segment by Application
  2.3.1 Non-Small Cell Lung Cancer (NSCLC)
  2.3.2 Thyroid Carcinoma
  2.3.3 Others
  2.3.4 Selpercatinib Capsules Sales by Application
    2.3.4.1 Global Selpercatinib Capsules Sale Market Share by Application (2021-2026)
    2.3.4.2 Global Selpercatinib Capsules Revenue and Market Share by Application (2021-2026)
    2.3.4.3 Global Selpercatinib Capsules Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Selpercatinib Capsules Breakdown Data by Company
  3.1.1 Global Selpercatinib Capsules Annual Sales by Company (2021-2026)
  3.1.2 Global Selpercatinib Capsules Sales Market Share by Company (2021-2026)
3.2 Global Selpercatinib Capsules Annual Revenue by Company (2021-2026)
  3.2.1 Global Selpercatinib Capsules Revenue by Company (2021-2026)
  3.2.2 Global Selpercatinib Capsules Revenue Market Share by Company (2021-2026)
3.3 Global Selpercatinib Capsules Sale Price by Company
3.4 Key Manufacturers Selpercatinib Capsules Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Selpercatinib Capsules Product Location Distribution
  3.4.2 Players Selpercatinib Capsules Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR SELPERCATINIB CAPSULES BY GEOGRAPHIC REGION

4.1 World Historic Selpercatinib Capsules Market Size by Geographic Region (2021-2026)
  4.1.1 Global Selpercatinib Capsules Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Selpercatinib Capsules Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Selpercatinib Capsules Market Size by Country/Region (2021-2026)
  4.2.1 Global Selpercatinib Capsules Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Selpercatinib Capsules Annual Revenue by Country/Region (2021-2026)
4.3 Americas Selpercatinib Capsules Sales Growth
4.4 APAC Selpercatinib Capsules Sales Growth
4.5 Europe Selpercatinib Capsules Sales Growth
4.6 Middle East & Africa Selpercatinib Capsules Sales Growth

5 AMERICAS

5.1 Americas Selpercatinib Capsules Sales by Country
  5.1.1 Americas Selpercatinib Capsules Sales by Country (2021-2026)
  5.1.2 Americas Selpercatinib Capsules Revenue by Country (2021-2026)
5.2 Americas Selpercatinib Capsules Sales by Specification (2021-2026)
5.3 Americas Selpercatinib Capsules Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Selpercatinib Capsules Sales by Region
  6.1.1 APAC Selpercatinib Capsules Sales by Region (2021-2026)
  6.1.2 APAC Selpercatinib Capsules Revenue by Region (2021-2026)
6.2 APAC Selpercatinib Capsules Sales by Specification (2021-2026)
6.3 APAC Selpercatinib Capsules Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Selpercatinib Capsules by Country
  7.1.1 Europe Selpercatinib Capsules Sales by Country (2021-2026)
  7.1.2 Europe Selpercatinib Capsules Revenue by Country (2021-2026)
7.2 Europe Selpercatinib Capsules Sales by Specification (2021-2026)
7.3 Europe Selpercatinib Capsules Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Selpercatinib Capsules by Country
  8.1.1 Middle East & Africa Selpercatinib Capsules Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Selpercatinib Capsules Revenue by Country (2021-2026)
8.2 Middle East & Africa Selpercatinib Capsules Sales by Specification (2021-2026)
8.3 Middle East & Africa Selpercatinib Capsules Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Selpercatinib Capsules
10.3 Manufacturing Process Analysis of Selpercatinib Capsules
10.4 Industry Chain Structure of Selpercatinib Capsules

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Selpercatinib Capsules Distributors
11.3 Selpercatinib Capsules Customer

12 WORLD FORECAST REVIEW FOR SELPERCATINIB CAPSULES BY GEOGRAPHIC REGION

12.1 Global Selpercatinib Capsules Market Size Forecast by Region
  12.1.1 Global Selpercatinib Capsules Forecast by Region (2027-2032)
  12.1.2 Global Selpercatinib Capsules Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Selpercatinib Capsules Forecast by Specification (2027-2032)
12.7 Global Selpercatinib Capsules Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Eli Lilly
  13.1.1 Eli Lilly Company Information
  13.1.2 Eli Lilly Selpercatinib Capsules Product Portfolios and Specifications
  13.1.3 Eli Lilly Selpercatinib Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Eli Lilly Main Business Overview
  13.1.5 Eli Lilly Latest Developments
13.2 Innovnent Biologics
  13.2.1 Innovnent Biologics Company Information
  13.2.2 Innovnent Biologics Selpercatinib Capsules Product Portfolios and Specifications
  13.2.3 Innovnent Biologics Selpercatinib Capsules Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Innovnent Biologics Main Business Overview
  13.2.5 Innovnent Biologics Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Selpercatinib Capsules Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Selpercatinib Capsules Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 40mg
Table 4. Major Players of 80mg
Table 5. Global Selpercatinib Capsules Sales by Specification (2021-2026) & (K Units)
Table 6. Global Selpercatinib Capsules Sales Market Share by Specification (2021-2026)
Table 7. Global Selpercatinib Capsules Revenue by Specification (2021-2026) & ($ million)
Table 8. Global Selpercatinib Capsules Revenue Market Share by Specification (2021-2026)
Table 9. Global Selpercatinib Capsules Sale Price by Specification (2021-2026) & (US$/Unit)
Table 10. Global Selpercatinib Capsules Sale by Application (2021-2026) & (K Units)
Table 11. Global Selpercatinib Capsules Sale Market Share by Application (2021-2026)
Table 12. Global Selpercatinib Capsules Revenue by Application (2021-2026) & ($ million)
Table 13. Global Selpercatinib Capsules Revenue Market Share by Application (2021-2026)
Table 14. Global Selpercatinib Capsules Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Selpercatinib Capsules Sales by Company (2021-2026) & (K Units)
Table 16. Global Selpercatinib Capsules Sales Market Share by Company (2021-2026)
Table 17. Global Selpercatinib Capsules Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Selpercatinib Capsules Revenue Market Share by Company (2021-2026)
Table 19. Global Selpercatinib Capsules Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Selpercatinib Capsules Producing Area Distribution and Sales Area
Table 21. Players Selpercatinib Capsules Products Offered
Table 22. Selpercatinib Capsules Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Selpercatinib Capsules Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Selpercatinib Capsules Sales Market Share Geographic Region (2021-2026)
Table 27. Global Selpercatinib Capsules Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Selpercatinib Capsules Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Selpercatinib Capsules Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Selpercatinib Capsules Sales Market Share by Country/Region (2021-2026)
Table 31. Global Selpercatinib Capsules Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Selpercatinib Capsules Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Selpercatinib Capsules Sales by Country (2021-2026) & (K Units)
Table 34. Americas Selpercatinib Capsules Sales Market Share by Country (2021-2026)
Table 35. Americas Selpercatinib Capsules Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Selpercatinib Capsules Sales by Specification (2021-2026) & (K Units)
Table 37. Americas Selpercatinib Capsules Sales by Application (2021-2026) & (K Units)
Table 38. APAC Selpercatinib Capsules Sales by Region (2021-2026) & (K Units)
Table 39. APAC Selpercatinib Capsules Sales Market Share by Region (2021-2026)
Table 40. APAC Selpercatinib Capsules Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Selpercatinib Capsules Sales by Specification (2021-2026) & (K Units)
Table 42. APAC Selpercatinib Capsules Sales by Application (2021-2026) & (K Units)
Table 43. Europe Selpercatinib Capsules Sales by Country (2021-2026) & (K Units)
Table 44. Europe Selpercatinib Capsules Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Selpercatinib Capsules Sales by Specification (2021-2026) & (K Units)
Table 46. Europe Selpercatinib Capsules Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Selpercatinib Capsules Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Selpercatinib Capsules Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Selpercatinib Capsules Sales by Specification (2021-2026) & (K Units)
Table 50. Middle East & Africa Selpercatinib Capsules Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Selpercatinib Capsules
Table 52. Key Market Challenges & Risks of Selpercatinib Capsules
Table 53. Key Industry Trends of Selpercatinib Capsules
Table 54. Selpercatinib Capsules Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Selpercatinib Capsules Distributors List
Table 57. Selpercatinib Capsules Customer List
Table 58. Global Selpercatinib Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Selpercatinib Capsules Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Selpercatinib Capsules Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Selpercatinib Capsules Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Selpercatinib Capsules Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Selpercatinib Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Selpercatinib Capsules Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Selpercatinib Capsules Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Selpercatinib Capsules Sales Forecast by Specification (2027-2032) & (K Units)
Table 69. Global Selpercatinib Capsules Revenue Forecast by Specification (2027-2032) & ($ millions)
Table 70. Global Selpercatinib Capsules Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Selpercatinib Capsules Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Eli Lilly Basic Information, Selpercatinib Capsules Manufacturing Base, Sales Area and Its Competitors
Table 73. Eli Lilly Selpercatinib Capsules Product Portfolios and Specifications
Table 74. Eli Lilly Selpercatinib Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Eli Lilly Main Business
Table 76. Eli Lilly Latest Developments
Table 77. Innovnent Biologics Basic Information, Selpercatinib Capsules Manufacturing Base, Sales Area and Its Competitors
Table 78. Innovnent Biologics Selpercatinib Capsules Product Portfolios and Specifications
Table 79. Innovnent Biologics Selpercatinib Capsules Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Innovnent Biologics Main Business
Table 81. Innovnent Biologics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Selpercatinib Capsules
Figure 2. Selpercatinib Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Selpercatinib Capsules Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Selpercatinib Capsules Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Selpercatinib Capsules Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Selpercatinib Capsules Sales Market Share by Country/Region (2025)
Figure 10. Selpercatinib Capsules Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 40mg
Figure 12. Product Picture of 80mg
Figure 13. Global Selpercatinib Capsules Sales Market Share by Specification in 2026
Figure 14. Global Selpercatinib Capsules Revenue Market Share by Specification (2021-2026)
Figure 15. Selpercatinib Capsules Consumed in Non-Small Cell Lung Cancer (NSCLC)
Figure 16. Global Selpercatinib Capsules Market: Non-Small Cell Lung Cancer (NSCLC) (2021-2026) & (K Units)
Figure 17. Selpercatinib Capsules Consumed in Thyroid Carcinoma
Figure 18. Global Selpercatinib Capsules Market: Thyroid Carcinoma (2021-2026) & (K Units)
Figure 19. Selpercatinib Capsules Consumed in Others
Figure 20. Global Selpercatinib Capsules Market: Others (2021-2026) & (K Units)
Figure 21. Global Selpercatinib Capsules Sale Market Share by Application (2025)
Figure 22. Global Selpercatinib Capsules Revenue Market Share by Application in 2026
Figure 23. Selpercatinib Capsules Sales by Company in 2026 (K Units)
Figure 24. Global Selpercatinib Capsules Sales Market Share by Company in 2026
Figure 25. Selpercatinib Capsules Revenue by Company in 2026 ($ millions)
Figure 26. Global Selpercatinib Capsules Revenue Market Share by Company in 2026
Figure 27. Global Selpercatinib Capsules Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Selpercatinib Capsules Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Selpercatinib Capsules Sales 2021-2026 (K Units)
Figure 30. Americas Selpercatinib Capsules Revenue 2021-2026 ($ millions)
Figure 31. APAC Selpercatinib Capsules Sales 2021-2026 (K Units)
Figure 32. APAC Selpercatinib Capsules Revenue 2021-2026 ($ millions)
Figure 33. Europe Selpercatinib Capsules Sales 2021-2026 (K Units)
Figure 34. Europe Selpercatinib Capsules Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Selpercatinib Capsules Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Selpercatinib Capsules Revenue 2021-2026 ($ millions)
Figure 37. Americas Selpercatinib Capsules Sales Market Share by Country in 2026
Figure 38. Americas Selpercatinib Capsules Revenue Market Share by Country (2021-2026)
Figure 39. Americas Selpercatinib Capsules Sales Market Share by Specification (2021-2026)
Figure 40. Americas Selpercatinib Capsules Sales Market Share by Application (2021-2026)
Figure 41. United States Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Selpercatinib Capsules Sales Market Share by Region in 2026
Figure 46. APAC Selpercatinib Capsules Revenue Market Share by Region (2021-2026)
Figure 47. APAC Selpercatinib Capsules Sales Market Share by Specification (2021-2026)
Figure 48. APAC Selpercatinib Capsules Sales Market Share by Application (2021-2026)
Figure 49. China Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 53. India Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Selpercatinib Capsules Sales Market Share by Country in 2026
Figure 57. Europe Selpercatinib Capsules Revenue Market Share by Country (2021-2026)
Figure 58. Europe Selpercatinib Capsules Sales Market Share by Specification (2021-2026)
Figure 59. Europe Selpercatinib Capsules Sales Market Share by Application (2021-2026)
Figure 60. Germany Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 61. France Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Selpercatinib Capsules Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Selpercatinib Capsules Sales Market Share by Specification (2021-2026)
Figure 67. Middle East & Africa Selpercatinib Capsules Sales Market Share by Application (2021-2026)
Figure 68. Egypt Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Selpercatinib Capsules Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Selpercatinib Capsules in 2026
Figure 74. Manufacturing Process Analysis of Selpercatinib Capsules
Figure 75. Industry Chain Structure of Selpercatinib Capsules
Figure 76. Channels of Distribution
Figure 77. Global Selpercatinib Capsules Sales Market Forecast by Region (2027-2032)
Figure 78. Global Selpercatinib Capsules Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Selpercatinib Capsules Sales Market Share Forecast by Specification (2027-2032)
Figure 80. Global Selpercatinib Capsules Revenue Market Share Forecast by Specification (2027-2032)
Figure 81. Global Selpercatinib Capsules Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Selpercatinib Capsules Revenue Market Share Forecast by Application (2027-2032)